VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Second-generation tyrosine kinase inhibitors as therapy for chronic myeloid leukemia.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Second-generation tyrosine kinase inhibitors as therapy for chronic myeloid leukemia.
Second-generation tyrosine kinase inhibitors as therapy for chronic myeloid leukemia. Curr Hematol Malig Rep. 2007 May; 2(2):83-8.
View in:
PubMed
subject areas
Animals
Benzamides
Clinical Trials as Topic
Dasatinib
Drug Delivery Systems
Drug Design
Drug Resistance, Neoplasm
Drug Screening Assays, Antitumor
Drugs, Investigational
Fusion Proteins, bcr-abl
Genes, abl
Humans
Imatinib Mesylate
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Leukemia, Myeloid, Chronic-Phase
Mice
Multicenter Studies as Topic
Mutation
Piperazines
Protein Isoforms
Protein Kinase Inhibitors
Pyrimidines
Signal Transduction
Thiazoles
authors with profiles
JORGE E CORTES
YESID ALVARADO